A trial last year against Novartis Pharmaceuticals Corp. featured shocking stories of sex discrimination against female sales representatives. One said her manager told her to get an abortion. Another claimed she was blamed for being raped during a work event.
But it was the cross-examination of Dr. Finis Welch, a key expert for Novartis, that tilted the trial toward the class in Velez v. Novartis Pharmaceuticals Corp., according to Katherine Kimpel and David Sanford, partners at Washington’s Sanford Wittels & Heisler, the lead plaintiffs’ lawyers.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]